The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma

BJU International

Volumn 92, Issue 1, 2003, Pages 125-130

  Gronlund Pakkanen S ^a   Wahlfors, J ^b   Talja, M ^c   Kosma, V M ^b   Pakkanen, T M ^a   Ala Opas, M ^d   Alhava, E ^a   Moore, R B ^e  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aminolaevulinic acid; Bladder cancer; Photodynamic therapy; Protoporphyrin IX; Urine cytology

Indexed keywords

AMINOLEVULINIC ACID; OXYGEN RADICAL; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGON LASER; ARTICLE; BLADDER CARCINOMA; BLADDER PERFORATION; BLADDER WALL; CATHETERIZATION; CONTROLLED STUDY; FEMALE; HISTOLOGY; INOCULATION; INTERMETHOD COMPARISON; LIGHT; LIPID PEROXIDATION; MICROSCOPY; MUSCLE NECROSIS; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; SUPERFICIAL CANCER; URINE CYTOLOGY;

ADMINISTRATION, INTRAVESICAL; AMINOLEVULINIC ACID; ANIMALS; FEMALE; INFUSIONS, INTRAVENOUS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; RATS; RATS, INBRED F344; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0038163697     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04290.x     Document Type: Article

References (29)

1. Wijkström H, Cohen SM, Gardiner RA et al. Prevention and treatment of urothelial premalignant and malignant lesions. Scand J Urol Nephrol Suppl 2000; 205: 116-35
2. Schapers RF, Pauwels RP, Wijnen JT et al. A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance and comparison with other prognostic parameters. Br J Urol 1994; 73: 625-31
3. Lamm DL, Riggs DR, Traynelis CL et al. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder. J Urol 1995; 153: 1444-50
4. Nseyo UO, DeHaven J, Dougherty TJ et al. Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. J Clin Laser Med Surg 1998; 16: 61-8
5. Manyak MJ. Photodynamic therapy principles and urologic applications. Semin Urol 1991; 9: 192-202
6. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275-92
7. Loh CS, MacRobert AJ, Bedwell J et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 1993; 68: 41-51
8. Grönlund-Pakkanen S, Mäkinen K, Talja M et al. The importance of fluorescence distribution and kinetics of ALA-induced PplX in the bladder in photodynamic therapy. J Photochem Photobiol B-Biol 1997; 38: 269-73
9. Mäkinen K, Grönlund-Pakkanen S, Tiirikainen M et al. Protoporphyrin-IX distribution and photodynamic effect in rat oesophagus after aminolaevulinic acid administration. Scand J Gastroenterol 1997; 32: 633-7
10. Pope AJ, Bown SG. Photodynamic therapy. Br J Urol 1991; 68: 1-9
11. Peng Q, Berg K, Moan J et al. 5-Aminolevulinic acid-based photodynamic therapy, principles and experimental research. J Photochem Photobiol B 1997; 65: 235-51
12. Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer 1992; 28A: 1734-42
13. Pope AJ, Bown SG. The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization. J Urol 1991; 145: 1064-70
14. Grönlund-Pakkanen S, Pakkanen TM, Talja M et al. The morphological changes in rat bladder after photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX. BJU Int 2000; 86: 126-32
15. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX basic principles and present clinical experience. J Photochem Photobiol B 1990; 6: 143-8
16. Kriegmair M, Baumgartner R, Lumper W et al. Early clinical experience with 5-aminolaevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol 1996; 77: 667-71
17. Xiao Z, Miller GG, McCallum TJ et al. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy. Photochem Photobiol 1998; 67: 573-83
18. Chang SC, MacRobert AJ, Bown SG. Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid. J Urol 1996; 155: 1744-8
19. Grönlund-Pakkanen S, Pakkanen TM, Koski E et al. Effect of photodynamic therapy on urinary bladder function: an experimental study with rats. Urol Res 2001; 29: 205-9
20. Leveckis J, Burn JL, Brown NJ et al. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder. J Urol 1994; 152: 550-3
21. Iinuma S, Bachor R, Flotte T et al. Biodistribution and phototoxicity of 5-aminolevulinic acid- induced PplX in an orthotopic rat bladder tumor model. J Urol 1995; 153: 802-6
22. Stocker S, Knuchel R, Sroka R et al. Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid. J Urol 1997; 157: 357-61
23. Xiao Z, McCallum TJ, Brown KM et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer 1999; 81: 638-46
24. Nseyo UO. Photodynamic therapy in the management of bladder cancer. J Clin Laser Med Surg 1996; 14: 271-80
25. Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905
26. Koss LG, Deitch D, Ramanathan R et al. Diagnostic value of cytology of voided urine. Acta Cytol 1985; 29: 810-6
27. Murphy WM, Soloway MS, Jukkola AF et al. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984; 53: 1555-65
28. Raitanen MP, Hellström P, Marttila T et al. Effect of intravesical instillations on the human complement factor H related protein (BTA stat) test. Eur Urol 2001; 40: 422-6
29. Grönlund-Pakkanen S, Wahlfors J, Mäkinen K et al. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma. J Urol 2002; 167: 1848-53